Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

NY-REN-34 Inhibitors

NY-REN-34 inhibitors are a class of chemical compounds designed to target and inhibit the activity of the NY-REN-34 protein, a molecule often associated with specific cellular functions. These inhibitors are typically small molecules that interfere with the active sites or regulatory domains of the NY-REN-34 protein, thereby blocking its normal biochemical activity. Structurally, NY-REN-34 inhibitors can vary widely, but they often share common features that allow them to bind specifically to the protein's functional motifs. This selectivity is crucial, as it enables them to exert their effect on NY-REN-34 without significantly affecting other proteins or cellular pathways. The development of these inhibitors relies heavily on structure-activity relationship (SAR) studies to optimize binding affinity and specificity, and advanced techniques like high-throughput screening and molecular docking are employed to identify promising candidates from large chemical libraries.

The mechanisms of action of NY-REN-34 inhibitors are diverse, depending on the inhibitor's mode of binding and interaction with the protein. Some inhibitors are competitive, directly competing with the substrate for binding to the active site, while others are allosteric, binding to a different region of the protein to induce conformational changes that reduce its activity. Understanding the conformational dynamics of NY-REN-34 is essential for designing effective inhibitors that can alter its functional state. The chemical scaffolds of these inhibitors often include heterocyclic cores, aromatic rings, and substituents that enhance hydrophobic or hydrogen-bonding interactions with the NY-REN-34 protein. Moreover, the physicochemical properties of these inhibitors, such as solubility, stability, and cell permeability, are carefully considered during their design and synthesis to ensure efficient modulation of the NY-REN-34 protein in a biological context. As a result, the development of NY-REN-34 inhibitors is a multidisciplinary effort involving organic chemistry, structural biology, and enzymology to understand and effectively target the protein.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

May demethylate the promoter of NY-REN-34, potentially influencing expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Could affect DNA methylation status, possibly influencing NY-REN-34 expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Histone deacetylase inhibitor that might affect NY-REN-34 expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

HDAC inhibitor that could potentially influence chromatin structure and NY-REN-34 expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

May influence histone acetylation and potentially NY-REN-34 expression.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Could affect histone modification and possibly the expression of NY-REN-34.

ITF2357

732302-99-7sc-364513
sc-364513A
5 mg
50 mg
$340.00
$1950.00
(0)

Might affect chromatin remodeling and influence NY-REN-34 expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Could influence histone modification states and NY-REN-34 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Affects histone acetylation and potentially NY-REN-34 expression.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Bromodomain inhibitor that might influence transcription factors affecting NY-REN-34 expression.